Cargando…
Combinatorial CRISPR/Cas9 Screening Reveals Epistatic Networks of Interacting Tumor Suppressor Genes and Therapeutic Targets in Human Breast Cancer
The majority of cancers are driven by multiple genetic alterations, but how these changes collaborate during tumorigenesis remains largely unknown. To gain mechanistic insights into tumor-promoting genetic interactions among tumor suppressor genes (TSG), we conducted combinatorial CRISPR screening c...
Autores principales: | Zhao, Xiaoyu, Li, Jinyu, Liu, Zhimin, Powers, Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762330/ https://www.ncbi.nlm.nih.gov/pubmed/34561273 http://dx.doi.org/10.1158/0008-5472.CAN-21-2555 |
Ejemplares similares
-
CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
por: Jiang, Long, et al.
Publicado: (2022) -
Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing
por: Sayed, Shady, et al.
Publicado: (2022) -
Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
por: Yao, Lijun, et al.
Publicado: (2023) -
PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer
por: Zhao, Zibo, et al.
Publicado: (2021) -
Leveraging Allele-Specific Expression for Therapeutic Response Gene Discovery in Glioblastoma
por: Sen, Arko, et al.
Publicado: (2022)